MASCC Symposium

New York, NY—Two major advances over the past decades have improved the management of febrile neutropenia (FN)—the MASCC (Multinational Association of Supportive Care in Cancer) scoring system for predicting the risk of FN, and the use of granulocyte colony-stimulating factors (G-CSFs) for the prevention of FN. However, the need for improvement still exists, said Jean Klastersky, MD, Professor, Institut Jules Bordet, Brussels, Belgium, at the 2012 MASCC International Symposium. Among the remaining challenges is refining the optimal use of these agents.

Read Article

New York, NY—Supportive care is effective in improving outcomes, but the growth of supportive care programs is hampered by economics, explained Eduardo Bruera, MD, Chair, Palliative Care & Rehabilitation Medicine, University of Texas M.D. Anderson Cancer Center, Houston, speaking at the 2012 Multinational Association of Supportive Care in Cancer International Symposium.
Read Article